GEODE CAPITAL MANAGEMENT, LLC - ZOMEDICA PHARMACEUTICALS COR ownership

ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 33 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ZOMEDICA PHARMACEUTICALS COR
ValueSharesWeighting
Q3 2020$199,000
+1558.3%
1,816,117
+3416.9%
0.00%
Q2 2020$12,000
-79.3%
51,640
-69.0%
0.00%
Q1 2019$58,000
-82.7%
166,364
-39.1%
0.00%
Q4 2018$336,000
+49.3%
273,310
+126.6%
0.00%
Q3 2018$225,000
-2.6%
120,590
+18.4%
0.00%
Q2 2018$231,000101,8650.00%
Other shareholders
ZOMEDICA PHARMACEUTICALS COR shareholders Q3 2020
NameSharesValueWeighting ↓
Cambridge Investment Research Advisors, Inc. 12,254,080$1,349,0000.01%
SABBY MANAGEMENT, LLC 470,548$52,0000.01%
jvl associates llc 58,500$6,0000.01%
WINTON GROUP Ltd 717,882$79,0000.00%
REILLY FINANCIAL ADVISORS, LLC 172,031$19,0000.00%
THOROUGHBRED FINANCIAL SERVICES, LLC 21,000$2,0000.00%
RETIREMENT INCOME SOLUTIONS, INC 32,060$3,000,0000.00%
JANE STREET GROUP, LLC 223,538$25,0000.00%
Sequoia Financial Advisors, LLC 15,000$2,0000.00%
UBS Group AG 105,639$12,0000.00%
View complete list of ZOMEDICA PHARMACEUTICALS COR shareholders